Back to Search
AGATA POZNIAK, DOULA
DOULA
NPI: 1417778721Individual
Specialties, Licenses & Credentials
DoulaPrimary
Doula
Code: 374J00000X
Research & Publications (20)
Successful use of darunavir, etravirine, enfuvirtide and tenofovir/emtricitabine in pregnant woman with multiclass HIV resistance.
PMID 19188762·AIDS·2009
5-case
Pharmacokinetics and safety of etravirine administered once or twice daily after 2 weeks treatment with efavirenz in healthy volunteers.
PMID 19620877·J Acquir Immune Defic Syndr·2009
2-rct
Pharmacokinetic interaction between nevirapine and darunavir with low-dose ritonavir in HIV-1-infected patients.
PMID 19660009·Br J Clin Pharmacol·2009
2-rct
Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm.
PMID 19439467·J Virol·2009
8-other
Elevated ethyl methanesulfonate (EMS) in nelfinavir mesylate (Viracept, Roche): overview.
PMID 19660105·AIDS Res Ther·2009
8-other
Pharmacology of second-line antituberculosis drugs and potential for interactions with antiretroviral agents.
PMID 19256042·AIDS·2009
6-review
The utility of nucleos(t)ide-only regimens in the treatment of Mycobacterium tuberculosis-HIV-1 coinfection.
PMID 19307940·AIDS·2009
8-other
Impact of different low-dose ritonavir regimens on lipids, CD36, and adipophilin expression.
PMID 19118379·Clin Pharmacol Ther·2009
4-observational
So you want to be ... a specialist in HIV/AIDS medicine.
PMID 19357591·Br J Hosp Med (Lond)·2009
8-other
Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers.
PMID 19329800·J Antimicrob Chemother·2009
8-other
Effect of baseline viral susceptibility on response to darunavir/ritonavir versus control protease inhibitors in treatment-experienced HIV type 1-infected patients: POWER 1 and 2.
PMID 18844462·AIDS Res Hum Retroviruses·2008
3-trial
Pharmacokinetics of atazanavir/ritonavir once daily and lopinavir/ritonavir twice and once daily over 72 h following drug cessation.
PMID 19043924·Antivir Ther·2008
3-trial
British HIV Association guidelines for immunization of HIV-infected adults 2008.
PMID 18983477·HIV Med·2008
6-review
Effects of different meal compositions and fasted state on the oral bioavailability of etravirine.
PMID 18823217·Pharmacotherapy·2008
3-trial
Factors influencing efavirenz and nevirapine plasma concentration: effect of ethnicity, weight and co-medication.
PMID 18771051·Antivir Ther·2008
8-other
Population trends in the prevalence and patterns of protease resistance related to exposure to unboosted and boosted protease inhibitors.
PMID 18839778·Antivir Ther·2008
4-observational
The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients.
PMID 18832879·AIDS·2008
3-trial
British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008.
PMID 18826546·HIV Med·2008
6-review
Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals.
PMID 18824460·J Antimicrob Chemother·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 GREGORY DR
HAMILTON, NJ 08690 - Phone
- (609) 690-0558
Quick Facts
- NPI
- 1417778721
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile